Interestingly, glucagon-like peptide-1 receptor agonists (GLP-1RAs), used in the treatment of T2DM and obesity, are known to show pro-cognitive and neuroprotective properties, and exert modulatory effects on immune, endocrine and metabolic processes in the central nervous system
Comprehensive care must also focus on mental health through approaches such as behavioral counseling
This means that GHK-Cu doesnt need to be applied at a certain time
When it's time for your first dose, a myAster nurse comes to your home to give the injection and show you exactly how it's done, so you feel confident doing it yourself from then on
AOD-9604 Safety: What Do Clinical Trials Show
Current Limitations GLP-1 medications are not yet FDA-approved for treating alcohol use disorder